{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:37:57Z","timestamp":1792805877379,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dehydrozingerone (DHZ) is an active ingredient of <jats:italic>Zingiber officinale<\/jats:italic> and structural half analogue of curcumin. In the present study, DHZ was evaluated for monoamine oxidase (MAO) inhibitory activity in silico and antidepressant activity in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>The\u00a0binding affinity of DHZ\u00a0with MAO-A (PDB ID: 2Z5Y) was assessed\u00a0using Schrodinger's Maestro followed by free energy calculation, pharmacokinetic property prediction using Qikprop and Molecular dynamics simulation using Desmond. In vivo antidepressant activity of DHZ was evaluated on C57 BL\/6 male mice using Escilatopram as the\u00a0standard\u00a0antidepressant. Open field test (OFT), forced swimming test (FST) and tail suspension test (TST) were used to evaluate the antidepressant effect of the drugs on days 1 and 7. Following\u00a0the behavioural study, neurotransmitters (noradrenaline, dopamine and serotonin) were estimated using liquid chromatography\u2013mass spectrometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>DHZ demonstrated a greater binding affinity for the MAO-A enzyme compared to moclobemide\u00a0in silico. Immobility in TST and FST were significantly (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.05) reduced in vivo with 100mg\/kg DHZ as compared to respective controls. DHZ treatment was more effective 1\u00a0h\u00a0post treatment compared to vehicle control. A significant increase in levels of neurotransmitters was observed in mice brain homogenate in response to DHZ treatment, reassuring its antidepressant-like potential.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>DHZ demonstrated MAO-A inhibition in silico, and the increased neurotransmitter levels in the brain in vivo were associated with an antidepressant-like effect.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s43440-021-00252-0","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T10:02:45Z","timestamp":1624874565000},"page":"1273-1286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies"],"prefix":"10.1007","volume":"73","author":[{"given":"Sudheer","family":"Moorkoth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Sai","family":"Prathyusha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Manandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runali","family":"Sankhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S. R.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4929-3954","authenticated-orcid":false,"given":"Nitesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"252_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","volume":"23","author":"TM Hillhouse","year":"2015","unstructured":"Hillhouse TM, Porter JH. A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol. 2015;23:1\u201321. https:\/\/doi.org\/10.1037\/a0038550.","journal-title":"Exp Clin Psychopharmacol"},{"key":"252_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejphar.2019.02.024","volume":"851","author":"GR Villas Boas","year":"2019","unstructured":"Villas Boas GR, Boerngen de Lacerda R, Paes MM, Gubert P, Almeida WLC, Rescia VC, et al. Molecular aspects of depression: a review from neurobiology to treatment. Eur J Pharmacol. 2019;851:99\u2013121. https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.024.","journal-title":"Eur J Pharmacol"},{"key":"252_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.kjms.2015.10.009","volume":"31","author":"S Yan","year":"2015","unstructured":"Yan S, You Z-L, Zhao Q-Y, Peng C, He G, Gou X, et al. Antidepressant-like effects of Sanyuansan in the mouse forced swim test, tail suspension test, and chronic mild stress model. Kaohsiung J Med Sci. 2015;31:605\u201312. https:\/\/doi.org\/10.1016\/j.kjms.2015.10.009.","journal-title":"Kaohsiung J Med Sci"},{"key":"252_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.31887\/DCNS.2006.8.2\/fduval","volume":"8","author":"F Duval","year":"2006","unstructured":"Duval F, Lebowitz BD, Macher J-P. Treatments in depression. Dialogues Clin Neurosci. 2006;8:191\u2013206.","journal-title":"Dialogues Clin Neurosci"},{"key":"252_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00131746-200407000-00005","volume":"10","author":"JG Fiedorowicz","year":"2004","unstructured":"Fiedorowicz JG, Swartz KL. The role of monoamine oxidase inhibitors in current psychiatric practice. J Psychiatr Pract. 2004;10:239\u201348.","journal-title":"J Psychiatr Pract"},{"key":"252_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4236\/ojd.2017.62004","volume":"06","author":"M Entzeroth","year":"2017","unstructured":"Entzeroth M, Ratty AK. Monoamine oxidase inhibitors\u2014revisiting a therapeutic principle. Open J Depress. 2017;06:31\u201368. https:\/\/doi.org\/10.4236\/ojd.2017.62004.","journal-title":"Open J Depress"},{"key":"252_CR7","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1073\/pnas.0710626105","volume":"105","author":"S-Y Son","year":"2008","unstructured":"Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T. Structure of human monoamine oxidase A at 2.2-A resolution: the control of opening the entry for substrates\/inhibitors. Proc Natl Acad Sci. 2008;105:5739\u201344. https:\/\/doi.org\/10.1073\/pnas.0710626105.","journal-title":"Proc Natl Acad Sci"},{"key":"252_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1515\/BMC.2011.030","volume":"2","author":"H Gaweska","year":"2011","unstructured":"Gaweska H, Fitzpatrick PF. Structures and mechanism of the monoamine oxidase family. Biomol Concepts. 2011;2:365\u201377. https:\/\/doi.org\/10.1515\/BMC.2011.030.","journal-title":"Biomol Concepts"},{"key":"252_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/BF02977752","volume":"28","author":"P-C Kuo","year":"2005","unstructured":"Kuo P-C, Cherng C-Y, Jeng J-F, Damu AG, Teng C-M, Lee E-J, et al. Isolation of a natural antioxidant, dehydrozingerone from Zingiber officinale and synthesis of its analogues for recognition of effective antioxidant and antityrosinase agents. Arch Pharm Res. 2005;28:518\u201328. https:\/\/doi.org\/10.1007\/BF02977752.","journal-title":"Arch Pharm Res"},{"key":"252_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bmc.2015.12.049","volume":"24","author":"GA Hampannavar","year":"2016","unstructured":"Hampannavar GA, Karpoormath R, Palkar MB, Shaikh MS. An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG). Bioorg Med Chem. 2016;24:501\u201320. https:\/\/doi.org\/10.1016\/j.bmc.2015.12.049.","journal-title":"Bioorg Med Chem"},{"key":"252_CR11","doi-asserted-by":"publisher","first-page":"26.1","DOI":"10.5667\/tang.2013.0009","volume":"3","author":"S Imtiyaz","year":"2013","unstructured":"Imtiyaz S, Rahman K, Sultana A, Tariq M, Chaudhary SS. Zingiber officinale Rosc.: a traditional herb with medicinal properties. CELLMED. 2013;3:26.1-26.7. https:\/\/doi.org\/10.5667\/tang.2013.0009.","journal-title":"CELLMED"},{"key":"252_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0378-8741(00)00242-7","volume":"73","author":"L Luo","year":"2000","unstructured":"Luo L, Nong Wang J, Kong LD, Jiang QG, Tan RX. Antidepressant effects of Banxia Houpu decoction, a traditional Chinese medicinal empirical formula. J Ethnopharmacol. 2000;73:277\u201381. https:\/\/doi.org\/10.1016\/S0378-8741(00)00242-7.","journal-title":"J Ethnopharmacol"},{"key":"252_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/213739","volume":"2013","author":"Z Ma","year":"2013","unstructured":"Ma Z, Ji W, Qu R, Wang M, Yang W, Zhan Z, et al. Metabonomic study on the antidepressant-like effects of banxia houpu decoction and its action mechanism. Evidence-Based Complement Altern Med. 2013;2013:1\u20139. https:\/\/doi.org\/10.1155\/2013\/213739.","journal-title":"Evidence-Based Complement Altern Med"},{"key":"252_CR14","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.pnpbp.2009.03.001","volume":"33","author":"L-T Yi","year":"2009","unstructured":"Yi L-T, Xu Q, Li Y-C, Yang L, Kong L-D. Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuro-Psychopharmacol Biol Psychiatry. 2009;33:616\u201324. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.03.001.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"252_CR15","doi-asserted-by":"publisher","first-page":"e1700077","DOI":"10.1002\/cbdv.201700077","volume":"14","author":"AZ Burmud\u017eija","year":"2017","unstructured":"Burmud\u017eija AZ, Mu\u0161kinja JM, Kosani\u0107 MM, Rankovi\u0107 BR, Novakovi\u0107 SB, \u0110or\u0111evi\u0107 SB, et al. Cytotoxic and antimicrobial activity of dehydrozingerone based cyclopropyl derivatives. Chem Biodivers. 2017;14:e1700077. https:\/\/doi.org\/10.1002\/cbdv.201700077.","journal-title":"Chem Biodivers"},{"key":"252_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13197-011-0488-8","volume":"51","author":"IR Kubra","year":"2014","unstructured":"Kubra IR, Bettadaiah BK, Murthy PS, Rao LJM. Structure\u2013function activity of dehydrozingerone and its derivatives as antioxidant and antimicrobial compounds. J Food Sci Technol. 2014;51:245\u201355. https:\/\/doi.org\/10.1007\/s13197-011-0488-8.","journal-title":"J Food Sci Technol"},{"key":"252_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1246485","author":"E Profumo","year":"2016","unstructured":"Profumo E, Buttari B, D\u2019Arcangelo D, Tinaburri L, Dettori MA, Fabbri D, et al. The nutraceutical dehydrozingerone and its dimer counteract inflammation- and oxidative stress-induced dysfunction of in vitro cultured human endothelial cells: a novel perspective for the prevention and therapy of atherosclerosis. Oxid Med Cell Longev. 2016. https:\/\/doi.org\/10.1155\/2016\/1246485.","journal-title":"Oxid Med Cell Longev"},{"key":"252_CR18","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.3390\/molecules25122737","volume":"25","author":"S Mapoung","year":"2020","unstructured":"Mapoung S, Suzuki S, Fuji S, Naiki-Ito A, Kato H, Yodkeeree S, et al. Dehydrozingerone, a curcumin analog, as a potential anti-prostate cancer inhibitor in vitro and in vivo. Molecules. 2020;25:2737. https:\/\/doi.org\/10.3390\/molecules25122737.","journal-title":"Molecules"},{"key":"252_CR19","doi-asserted-by":"publisher","first-page":"S116","DOI":"10.4103\/0973-1296.182168","volume":"12","author":"DK Khatri","year":"2016","unstructured":"Khatri DK, Juvekar AR. Kinetics of inhibition of monoamine oxidase using curcumin and ellagic acid. Pharmacogn Mag. 2016;12:S116\u201320. https:\/\/doi.org\/10.4103\/0973-1296.182168.","journal-title":"Pharmacogn Mag"},{"key":"252_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00213-008-1300-y","volume":"201","author":"SK Kulkarni","year":"2008","unstructured":"Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology. 2008;201:435\u201342. https:\/\/doi.org\/10.1007\/s00213-008-1300-y.","journal-title":"Psychopharmacology"},{"key":"252_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8361858","volume":"2019","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Hamada H, Gerk PM. Selectivity of dietary phenolics for inhibition of human monoamine oxidases A and B. Biomed Res Int. 2019;2019:1\u201312. https:\/\/doi.org\/10.1155\/2019\/8361858.","journal-title":"Biomed Res Int"},{"key":"252_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pbb.2014.10.010","volume":"127","author":"DM Martinez","year":"2014","unstructured":"Martinez DM, Barcellos A, Casaril AM, Savegnago L, Lernard\u00e3o EJ. Antidepressant-like activity of dehydrozingerone: Involvement of the serotonergic and noradrenergic systems. Pharmacol Biochem Behav. 2014;127:111\u20137. https:\/\/doi.org\/10.1016\/j.pbb.2014.10.010.","journal-title":"Pharmacol Biochem Behav"},{"key":"252_CR23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1021\/acs.jcim.7b00048","volume":"57","author":"J Ash","year":"2017","unstructured":"Ash J, Fourches D. Characterizing the chemical space of ERK2 kinase inhibitors using descriptors computed from molecular dynamics trajectories. J Chem Inf Model. 2017;57:1286\u201399. https:\/\/doi.org\/10.1021\/acs.jcim.7b00048.","journal-title":"J Chem Inf Model"},{"key":"252_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004;47:1739\u201349. https:\/\/doi.org\/10.1021\/jm0306430.","journal-title":"J Med Chem"},{"issue":"11","key":"252_CR25","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1080\/07391102.2019.1660218","volume":"38","author":"K Sahin","year":"2020","unstructured":"Sahin K, Zengin Kurt B, Sonmez F, Durdagi S. Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays. J Biomol Struct Dyn. 2020;38(11):3342\u201358. https:\/\/doi.org\/10.1080\/07391102.2019.1660218.","journal-title":"J Biomol Struct Dyn"},{"key":"252_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ps.263","volume":"57","author":"M Agarwal","year":"2001","unstructured":"Agarwal M, Walia S, Dhingra S, Khambay BP. Insect growth inhibition, antifeedant and antifungal activity of compounds isolated\/derived from Zingiber officinale Roscoe (ginger) rhizomes. Pest Manag Sci. 2001;57:289\u2013300. https:\/\/doi.org\/10.1002\/ps.263.","journal-title":"Pest Manag Sci"},{"key":"252_CR27","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/0960327112462728","volume":"32","author":"MJ Anwar","year":"2013","unstructured":"Anwar MJ, Pillai KK, Samad A, Vohora D. Effect of escitalopram on cardiomyopathy-induced anxiety in mice. Hum Exp Toxicol. 2013;32:632\u20139. https:\/\/doi.org\/10.1177\/0960327112462728.","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"252_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7860\/JCDR\/2014\/7482.4098","volume":"8","author":"SR Kadali","year":"2014","unstructured":"Kadali SR, Das MC, Rao ASRS, Sri GK. Antidepressant activity of brahmi in albino mice. J Clin Diagnostic Res. 2014;8(3):35\u20137. https:\/\/doi.org\/10.7860\/JCDR\/2014\/7482.4098.","journal-title":"J Clin Diagnostic Res"},{"key":"252_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3892\/br.2019.1226","volume":"11","author":"A Rai","year":"2019","unstructured":"Rai A, Gill M, Kinra M, Shetty R, Krishnadas N, Rao CM, et al. Catechin ameliorates depressive symptoms in Sprague Dawley rats subjected to chronic unpredictable mild stress by decreasing oxidative stress. Biomed Rep. 2019;11:79\u201384. https:\/\/doi.org\/10.3892\/br.2019.1226.","journal-title":"Biomed Rep"},{"key":"252_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85:367\u201370. https:\/\/doi.org\/10.1007\/BF00428203.","journal-title":"Psychopharmacology"},{"key":"252_CR31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/WNR.0000000000000944","volume":"29","author":"M Gill","year":"2018","unstructured":"Gill M, Kinra M, Rai A, Chamallamudi MR, Kumar N. Evaluation of antidepressant activity of methanolic extract of Saraca asoca bark in a chronic unpredictable mild stress model. NeuroReport. 2018;29:134\u201340. https:\/\/doi.org\/10.1097\/WNR.0000000000000944.","journal-title":"NeuroReport"},{"key":"252_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3940(03)00306-9","volume":"343","author":"M Mantovani","year":"2003","unstructured":"Mantovani M, P\u00e9rtile R, Calixto JB, Santos ARS, Rodrigues ALS. Melatonin exerts an antidepressant-like effect in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the l-arginine\u2013nitric oxide pathway. Neurosci Lett. 2003;343:1\u20134. https:\/\/doi.org\/10.1016\/S0304-3940(03)00306-9.","journal-title":"Neurosci Lett"},{"key":"252_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4196\/kjpp.2014.18.5.365","volume":"18","author":"N Kumar","year":"2014","unstructured":"Kumar N, Dhayabaran D, Nampoothiri M, Nandakumar K, Puratchikody A, Lalani N, et al. Atypical antidepressant activity of 3, 4-Bis (3, 4-dimethoxyphenyl) furan-2, 5-dione isolated from heart wood of Cedrus deodara, in rodents. Korean J Physiol Pharmacol. 2014;18:365\u20139. https:\/\/doi.org\/10.4196\/kjpp.2014.18.5.365.","journal-title":"Korean J Physiol Pharmacol"},{"key":"252_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/506870","volume":"2014","author":"T-H Kim","year":"2014","unstructured":"Kim T-H, Choi J, Kim H-G, Kim HR. Quantification of neurotransmitters in mouse brain tissue by using liquid chromatography coupled electrospray tandem mass spectrometry. J Anal Methods Chem. 2014;2014:1\u201311. https:\/\/doi.org\/10.1155\/2014\/506870.","journal-title":"J Anal Methods Chem"},{"key":"252_CR35","doi-asserted-by":"publisher","first-page":"12684","DOI":"10.1073\/pnas.0505975102","volume":"102","author":"L De Colibus","year":"2005","unstructured":"De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A. Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci USA. 2005;102:12684\u20139. https:\/\/doi.org\/10.1073\/pnas.0505975102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"252_CR36","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2174\/1570159X15666171128143650","volume":"16","author":"P Dhiman","year":"2018","unstructured":"Dhiman P, Malik N, Khatkar A. 3D-QSAR and in-silico studies of natural products and related derivatives as monoamine oxidase inhibitors. Curr Neuropharmacol. 2018;16:881\u2013900. https:\/\/doi.org\/10.2174\/1570159X15666171128143650.","journal-title":"Curr Neuropharmacol"},{"key":"252_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.36468\/pharmaceutical-sciences.687","volume":"82","author":"PS Nallella","year":"2020","unstructured":"Nallella PS, Kumar NMS. An assessment of crosstalk between serotonin and dopamine systems after escitalopram treatment using LC\u2013MS technique with ion-trap analyser. Indian J Pharm Sci. 2020;82:612\u201321.","journal-title":"Indian J Pharm Sci"},{"key":"252_CR38","first-page":"125","volume":"6","author":"AH Rahmani","year":"2014","unstructured":"Rahmani AH, Shabrmi FMA, Aly SM. Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities. Int J Physiol Pathophysiol Pharmacol. 2014;6:125\u201336.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"252_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/jmf.2007.0660","volume":"12","author":"SW Chung","year":"2009","unstructured":"Chung SW, Kim MK, Chung JH, Kim DH, Choi JS, Anton S, et al. Peroxisome proliferator-activated receptor activation by a short-term feeding of zingerone in aged rats. J Med Food. 2009;12:345\u201350. https:\/\/doi.org\/10.1089\/jmf.2007.0660.","journal-title":"J Med Food"},{"key":"252_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/142979","author":"S Prasad","year":"2015","unstructured":"Prasad S, Tyagi AK. Ginger and its constituents: role in prevention and treatment of gastrointestinal cancer. Gastroenterol Res Pract. 2015. https:\/\/doi.org\/10.1155\/2015\/142979.","journal-title":"Gastroenterol Res Pract"},{"key":"252_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.pnpbp.2003.11.018","volume":"28","author":"AS Elhwuegi","year":"2004","unstructured":"Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2004;28:435\u201351. https:\/\/doi.org\/10.1016\/j.pnpbp.2003.11.018.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"252_CR42","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3:935\u201349. https:\/\/doi.org\/10.1038\/nrd1549.","journal-title":"Nat Rev Drug Discov"},{"key":"252_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/AABC.S105289","volume":"9","author":"J de Ruyck","year":"2016","unstructured":"de Ruyck J, Brysbaert G, Blossey R, Lensink M. Molecular docking as a popular tool in drug design, an in silico travel. Adv Appl Bioinform Chem. 2016;9:1\u201311. https:\/\/doi.org\/10.2147\/AABC.S105289.","journal-title":"Adv Appl Bioinform Chem"},{"key":"252_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.compbiolchem.2019.01.012","volume":"79","author":"N Agrawal","year":"2019","unstructured":"Agrawal N, Mishra P. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents. Comput Biol Chem. 2019;79:63\u201372. https:\/\/doi.org\/10.1016\/j.compbiolchem.2019.01.012.","journal-title":"Comput Biol Chem"},{"key":"252_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","volume":"47","author":"RD Porsolt","year":"1978","unstructured":"Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol. 1978;47:379\u201391. https:\/\/doi.org\/10.1016\/0014-2999(78)90118-8.","journal-title":"Eur J Pharmacol"},{"key":"252_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuint.2007.04.006","volume":"52","author":"JP Kiss","year":"2008","unstructured":"Kiss JP. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression. Neurochem Int. 2008;52:34\u20139. https:\/\/doi.org\/10.1016\/j.neuint.2007.04.006.","journal-title":"Neurochem Int"},{"key":"252_CR47","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(17)32802-7.","journal-title":"Lancet"},{"key":"252_CR48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1586\/14737175.2016.1158647","volume":"16","author":"C Hiemke","year":"2016","unstructured":"Hiemke C. Why do antidepressant therapies have such a poor success rate? Expert Rev Neurother. 2016;16:597\u20139. https:\/\/doi.org\/10.1586\/14737175.2016.1158647.","journal-title":"Expert Rev Neurother"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-021-00252-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-021-00252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T10:44:14Z","timestamp":1632480254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-021-00252-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1007\/s43440-021-00252-0","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"20 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}